Synmosa Biopharma Corp operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Synmosa Biopharma Corp with three other
companies in this sector in Taiwan:
Formosa Laboratories, Inc
sales of 2.69 billion Taiwanese Dollars [US$88.10 million]
of which 100%
was Active Pharmaceutical Ingredient),
Nang Kuang Pharmaceutical Co., Ltd
(1.54 billion Taiwanese Dollars [US$50.43 million]
of which 93%
was Western medicine), and
Sinphar Pharmaceutical C O., Ltd.
(2.22 billion Taiwanese Dollars [US$72.64 million]
of which 69%
Synmosa Biopharma Corp reported sales of 2.36 billion Taiwanese Dollars (US$77.47 million)
December of 2018.
increase of 27.0%
versus 2017, when the company's sales were 1.86 billion Taiwanese Dollars.
Sales of Material Drugs saw an increase
that was more than double the company's growth rate: sales were up
92.7% in 2018, from
72.51 million Taiwanese Dollars to 139.77 million Taiwanese Dollars.